|
GDAP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.74219999982128E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.84040000303665E-08 |
| Normal-vs-Stage2 |
4.782600E-03 |
| Normal-vs-Stage3 |
2.359500E-02 |
| Normal-vs-Stage4 |
1.436630E-03 |
| Stage1-vs-Stage2 |
3.579800E-01 |
| Stage1-vs-Stage3 |
3.831800E-01 |
| Stage1-vs-Stage4 |
9.340400E-01 |
| Stage2-vs-Stage3 |
9.672000E-01 |
| Stage2-vs-Stage4 |
5.017200E-01 |
| Stage3-vs-Stage4 |
5.637600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.30289999958444E-07 |
| Normal-vs-AfricanAmerican |
2.89149999999072E-06 |
| Normal-vs-Asian |
2.812000E-01 |
| Caucasian-vs-AfricanAmerican |
6.870400E-01 |
| Caucasian-vs-Asian |
7.985400E-01 |
| AfricanAmerican-vs-Asian |
7.064800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.82999995344136E-09 |
| Normal-vs-Female |
1.217970E-02 |
| Male-vs-Female |
7.617900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.22279999999575E-05 |
| Normal-vs-Extreme_Weight |
5.44349998410354E-09 |
| Normal-vs-Obese |
5.72079999999753E-05 |
| Normal-vs-Extreme_Obese |
7.828300E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.856800E-01 |
| Normal_Weight-vs-Obese |
5.030800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.893400E-01 |
| Extreme_Weight-vs-Obese |
1.082590E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.980000E-01 |
| Obese-vs-Extreme_Obese |
8.637800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.584590E-01 |
| Normal-vs-Age(41-60Yrs) |
2.9307000000145E-06 |
| Normal-vs-Age(61-80Yrs) |
9.61470000282461E-08 |
| Normal-vs-Age(81-100Yrs) |
3.22520000040072E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.010200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.096000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.529800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.563200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.381550E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.104200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.40269999954401E-08 |
| Normal-VS-Type2 PRCC |
1.64431999999382E-05 |
| Normal-VS-KIRP CIMP |
4.326600E-01 |
| Normal-VS-Unclassified PRCC |
1.740320E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.927600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.084100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.532200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.900620E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.700030E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.099000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.29919999705785E-08 |
| Normal-vs-N1 |
1.430050E-01 |
| Normal-vs-N2 |
4.532000E-01 |
| N0-vs-N1 |
7.484200E-02 |
| N0-vs-N2 |
3.421400E-01 |
| N1-vs-N2 |
8.478000E-01 |
|
|
